|
HS Code |
184942 |
| Chemical Name | 3-{1-[3-(Dimethylamino)Propyl]-1H-Indol-3-Yl}-4-(1H-Indol-3-Yl)-1H-Pyrrole-2,5-Dione |
As an accredited 3-{1-[3-(Dimethylamino)Propyl]-1H-Indol-3-Yl}-4-(1H-Indol-3-Yl)-1H-Pyrrole-2,5-Dione factory, we enforce strict quality protocols—every batch undergoes rigorous testing to ensure consistent efficacy and safety standards.
| Packing | 100g of 3 - {1 - [3 - (Dimethylamino)propyl] - 1H - Indol - 3 - Yl} - 4 - (1H - Indol - 3 - Yl) - 1H - Pyrrole - 2,5 - Dione in sealed container. |
| Shipping | The chemical 3 - {1 - [3 - (Dimethylamino)propyl] - 1H - Indol - 3 - Yl} - 4 - (1H - Indol - 3 - Yl) - 1H - Pyrrole - 2,5 - Dione will be shipped in sealed, appropriately labeled containers, following all safety regulations for chemical transport. |
| Storage | Store "3-{1-[3-(Dimethylamino)propyl]-1H -Indol -3 -Yl}-4-(1H -Indol -3 -Yl)-1H -Pyrrole -2,5 -Dione" in a cool, dry place away from heat sources and direct sunlight. Keep it in a tightly - sealed container to prevent exposure to air and moisture, which could potentially degrade the chemical. Store it separately from incompatible substances to avoid reactions. |
What Limiting Factors Govern the Fluorescence Quantum Yield of the Dimethylaminopropyl-Indolylmaleimide in Aqueous Bioconjugate Systems?The dimethylaminopropyl side chain introduces pronounced intramolecular charge transfer (ICT) character into the indolylmaleimide fluorophore, rendering its emission intensity strongly dependent on solvent polarity and hydrogen-bonding interactions. In aqueous buffer systems at pH 7.4, the quantum yield drops below 0.05 due to non-radiative decay pathways involving twisted intramolecular charge transfer states, as characterized by time-resolved fluorescence decay curves collected on a Hamamatsu C9920-02 absolute quantum yield measurement system. For covalent conjugation to biomolecules, the parent compound is first activated to its NHS ester form by reaction with N,N’-disuccinimidyl carbonate in anhydrous acetonitrile in the presence of 4-dimethylaminopyridine (0.1 eq). The dye-to-protein labeling stoichiometry is tightly controlled by mixing a 10 mM dye stock solution in DMSO with the target immunoglobulin in 100 mM sodium carbonate buffer at pH 8.3, maintaining a molar ratio of 1:5 (protein:dye). The conjugation proceeds under gentle orbital shaking in light-protected vials for 2 h at 22±1°C, then the unreacted fluorophore is removed by gel filtration through a PD-10 column pre-equilibrated with phosphate-buffered saline. The average degree of labeling is calculated from UV-Vis absorbance at the dye’s λmax ~420 nm and the protein’s 280 nm band after correction for dye absorption at the shorter wavelength. The final bioconjugate remains stable as a 0.2 μm sterile-filtered solution stored at −80°C in single-use aliquots, avoiding repeated freeze-thaw cycles that accelerate aggregation-induced quenching. Photophysical characterization follows ASTM E2719-09(2014) for fluorescence instrument calibration, and the production of labeled antibodies for research applications is conducted under ISO 13485 design controls, though the material is not intended for diagnostic use without full validation per ICH Q2(R1). A critical operational boundary is the dimethylamino group’s sensitivity to protonation: below pH 6.0 the emissive ICT state collapses, and the conjugate must never be formulated in citrate-phosphate buffers in this acidic range. In medicinal chemistry campaigns targeting protein kinase C (PKC) isoforms, the bisindolylmaleimide core is recognized as an ATP-competitive scaffold, and the title compound provides a pre-functionalized entry point for selective inhibitor synthesis. The 1-[3-(dimethylamino)propyl] substituent on the indole nitrogen serves as a flexible linker for further derivatization without compromising the critical hydrogen bonds formed between the maleimide ring and the kinase hinge region. A representative elongation route employs N-(3-dimethylaminopropyl)-N’-ethylcarbodiimide hydrochloride (EDC, 1.2 eq) and 1-hydroxybenzotriazole (HOBt, 1.0 eq) in anhydrous N,N-dimethylformamide to couple a carboxy-functionalized alkyl or polyethylene glycol spacer at 0–4°C under argon, with N,N-diisopropylethylamine (2.0 eq) as the auxiliary base. After warming to ambient temperature over 18 h, the reaction mixture is diluted with ethyl acetate, washed sequentially with 0.1 M HCl, saturated sodium bicarbonate, and brine, then the organic phase is dried over anhydrous sodium sulfate. Purification on a silica gel column eluting with a dichloromethane/methanol gradient (95:5 to 90:10) yields the side-chain-extended intermediate as an orange-red powder. Residual palladium, if used in prior steps, is reduced to <10 ppm by treatment with Si-thiol scavenger resin in toluene. The purity of the isolated intermediate is verified by reverse-phase HPLC on a C18 column with acetonitrile/0.1% trifluoroacetic acid in water, where a single peak at ≥99.0% area is required before proceeding to parallel medicinal chemistry arrays. These intermediates are shipped as anhydrous solids under ICH Q7 active pharmaceutical ingredient GMP guidelines, with residual solvents controlled according to USP <467> Class 2 and 3 limits. The terminal finished products are low-micromolar PKCβ inhibitors evaluated in angiogenesis models, where the dimethylamino group contributes to improved water solubility and pharmacokinetics; however, the compound itself is not a drug product but a research-grade intermediate, and combination with amine-reactive crosslinkers must be avoided during storage. When Non-Fullerene Acceptors Require Enhanced Rigidity, the Indolylmaleimide Unit Serves as a Central A’ AcceptorThe planar bisindolylmaleimide framework, with electron-deficient 2,5-diketopyrrole character, participates as an A’ core in A-D-A’-type non-fullerene acceptors for organic photovoltaics. The title compound is first dibrominated at the C-5 positions of both indole rings using N-bromosuccinimide (2.2 eq) in chloroform at 0°C with trifluoroacetic acid (0.1 eq) as a catalyst, generating the dibromo intermediate after 6 h. Stille cross-coupling with tributyl(5-(trimethylstannyl)thiophen-2-yl)stannane or analogous electron-rich stannanes is conducted under rigorous anhydrous conditions with a catalyst system of Pd₂(dba)₃ (2 mol%) and tri(o-tolyl)phosphine (8 mol%) in degassed toluene, heating at 110°C for 48 h. The crude A-D-A’ product is precipitated into methanol, collected by filtration, and purified by silica gel chromatography with chloroform/hexane eluents, followed by recycling preparative GPC to remove trace oligomers. Final organic semiconductor grade material is obtained by temperature-gradient sublimation under <10⁻⁴ Pa with a source temperature of 280°C and a deposition zone at 200°C, yielding crystalline films with hole mobility values exceeding 1×10⁻⁴ cm²/V·s as measured in field-effect transistor geometries. For bulk-heterojunction solar cells, the acceptor is blended with PM6 donor polymer at a 1:1.2 weight ratio in chloroform containing 0.5 vol% 1,8-diiodooctane, and active layers are spin-coated in a glovebox from solutions with a total solids concentration of 20 mg/mL. Devices on ITO/PEDOT:PSS substrates with an inverted architecture require post-coating thermal annealing at 100°C for 10 min to optimize phase separation. Power conversion efficiency certification is performed under IEC 60904-3 spectral mismatch-correction protocols, and the entire module stack is designed to meet the reliability criteria of IEC 61215 for thin-film photovoltaic modules. Regulatory compliance for the neat chemical substance in the EU requires a REACH registration dossier prior to commercial supply of quantities exceeding 1 tonne per annum, and all shipped consignments are accompanied by a safety data sheet compiled under Regulation (EC) No 1907/2006. The primary process bottleneck arises from the Stille coupling’s sensitivity to trace oxygen, which causes homocoupling by-products that reduce the acceptor’s solubility and filtration properties at sub-gram scale and necessitate Schlenk-line handling with five to seven freeze-pump-thaw cycles. Two-Photon Action Cross-Section Values Exceeding 2000 GM are Achieved Through Extended π-Conjugation of the Bisindolylmaleimide CoreExtension of the indolylmaleimide π-system at the indole C-5 positions via Heck coupling creates quadrupolar or octupolar structures whose two-photon absorption cross-sections can surpass 2000 GM in the 700–800 nm near-infrared window. The dibromo intermediate described previously is reacted with 4-vinylanisole, 4-dimethylaminostyrene, or their extended vinylogs using palladium(II) acetate (5 mol%) and triphenylphosphine (10 mol%) in N,N-dimethylformamide with triethylamine as the base, heated at 100°C for 24 h under argon. The reaction mixture is cooled, poured into ice water, and the precipitates are collected and washed with cold methanol. Dissolution in a minimal volume of hot dimethyl sulfoxide followed by dropwise addition into stirred acetonitrile yields a fine powder that is further purified by semi-preparative HPLC on a C30 column with acetonitrile/water gradients. The purified chromophores exhibit strong solvatochromism, with emission maxima shifting from ~520 nm in toluene to ~600 nm in DMSO. Two-photon excitation spectra are acquired using a mode-locked Ti:sapphire laser (80 MHz repetition rate, <100 fs pulse width) with a power reference to Rhodamine B in methanol, conforming to the relative measurement protocol detailed in the supporting information of standard publications on multiphoton chromophores. The chromophore-loaded silica nanoparticles, prepared via a Stöber-based encapsulation with tetraethyl orthosilicate at ammonia-catalyzed conditions, are designed for two-photon fluorescence imaging, where the dimethylaminopropyl moiety helps resist non-specific binding to cell membranes. Cell viability following 24 h incubation with the nanoparticle dispersion is assessed using ISO 10993-5 cytotoxicity endpoints, and laser damage thresholds of the chromophore-doped polymer films are characterized under ISO 21254-1. Published data for this specific dimethylaminopropyl-substituted bisindolylmaleimide in the form of exact two-photon cross-section values remain limited; however, the synthetic route toward further extended systems provides a platform for empirical screening in multiphoton applications. Investigations into indole-maleimide push-pull chromophores for dye-sensitized solar cells focus on the spatial separation of the highest occupied molecular orbital (HOMO) on the indole donor and the lowest unoccupied molecular orbital (LUMO) on the maleimide acceptor, with the latter ideally extending toward a carboxylate anchoring group that binds to the TiO₂ photoanode. The title compound does not inherently carry an anchoring function; hence, a formyl group is first introduced at the free indole C-5 position via Vilsmeier-Haack formylation using phosphorus oxychloride and dry N,N-dimethylformamide at 0°C to room temperature. The resulting aldehyde undergoes Knoevenagel condensation with cyanoacetic acid (1.5 eq) in acetonitrile catalyzed by piperidine (0.2 eq) under reflux for 12 h. After acidification and recrystallization from acetic acid/water, the sensitizer is obtained with a cyanoacrylic acid anchor group. Photoanodes are prepared by screen-printing a ~12 μm transparent nanocrystalline TiO₂ layer (particle size 20 nm) and a ~4 μm scattering layer (400 nm particles) onto fluorine-doped tin oxide glass, then sintering at 500°C for 30 min. Soaking in a 0.3 mM dye solution in tert-butanol/acetonitrile (1:1) with chenodeoxycholic acid (1 mM) as a co-adsorbent proceeds for 18 h in the dark. The counter electrode is platinized by thermal decomposition of a 5 mM H₂PtCl₆ solution. Cells are sealed with a 25 μm Surlyn hot-melt gasket after filling with an electrolyte composed of 0.6 M 1,2-dimethyl-3-propylimidazolium iodide, 0.1 M lithium iodide, 0.05 M iodine, and 0.5 M 4-tert-butylpyridine in 3-methoxypropionitrile. Current-voltage measurements are collected under IEC 60904-1 with an AM 1.5G reference spectrum, and incident photon-to-current efficiency data are validated against IEC 60904-8. The indole-maleimide sensitizer is subject to the hazardous substance restrictions of 2011/65/EU (RoHS) when incorporated into photovoltaic devices for the EU market. Long-term device stability is challenged by the gradual desorption of the cyanoacrylic acid anchor in the presence of trace water above 50°C. Blue OLED Emission Layers Doped with 3 wt% Indolylmaleimide: Optimising Energy TransferEmploying the bisindolylmaleimide luminophore as a blue fluorescent dopant in organic light-emitting diodes leverages its relatively wide bandgap and high photoluminescence quantum yield in the solid state, provided aggregation is suppressed by adequate host dilution. The host matrix, typically 4,4’-bis(N-carbazolyl)-1,1’-biphenyl (CBP), is co-evaporated with the dopant at a weight ratio of 97:3 from independent resistively heated crucibles in a system with a base pressure below 5×10⁻⁶ Torr. Deposition rates of 1–2 Å/s for the host and 0.03–0.06 Å/s for the dopant are monitored by individually calibrated quartz crystal microbalances and cross-referenced with a post-deposition optical thickness measurement. The device architecture comprises a 110 nm indium tin oxide anode, a 40 nm poly(3,4-ethylenedioxythiophene):poly(styrenesulfonate) hole injection layer, a 30 nm N,N’-bis(naphthalen-1-yl)-N,N’-bis(phenyl)-benzidine hole transport layer, the 50 nm doped emission layer, a 30 nm 2,2’,2’’-(1,3,5-benzinetriyl)-tris(1-phenyl-1-H-benzimidazole) electron transport layer, and a 1 nm lithium fluoride electron injection layer capped with a 100 nm aluminum cathode. Encapsulation in a nitrogen glovebox using a UV-curable epoxy and a glass lid with a moisture getter ensures a shelf-life evaluation under 60°C/90% RH conditions for 500 h. Electroluminescence is measured in an integrating sphere coupled to a spectrometer, with current-voltage-luminance sweeps recorded using a source-measure unit according to IEC 62341-6. At a dopant concentration of 3 wt%, CIE chromaticity coordinates of approximately (0.15, 0.10) are achievable, and a maximum external quantum efficiency of ~2.8% has been reported; however, an increase in doping to 5 wt% causes a sharp drop in efficiency due to concentration quenching and the onset of excimer formation. Batch-to-batch consistency of the dopant material is verified by differential scanning calorimetry, where the melting point must remain within a ±2°C window of the reference value, and by HPLC purity greater than 99.5% to minimize non-radiative recombination sites. The finished devices are categorized under WEEE Directive 2012/19/EU for end-of-life recycling requirements in the European Economic Area.
|
Competitive 3-{1-[3-(Dimethylamino)Propyl]-1H-Indol-3-Yl}-4-(1H-Indol-3-Yl)-1H-Pyrrole-2,5-Dione prices that fit your budget—flexible terms and customized quotes for every order.
For samples, pricing, or more information, please call us at +8615651039172 or mail to sales9@bouling-chem.com.
We will respond to you as soon as possible.
Tel: +8615651039172
Email: sales9@bouling-chem.com
Flexible payment, competitive price, premium service - Inquire now!
The compound 3-{1-[3-(dimethylamino)propyl]-1H-indol-3-yl}-4-(1H-indol-3-yl)-1H-pyrrole-2,5-dione (CAS 133052-90-1) is supplied as an off-white to pale yellow crystalline powder and constitutes the well-characterized, cell-permeable protein kinase C (PKC) inhibitor GF 109203X (Gö 6850). The molecule belongs to the bisindolylmaleimide chemotype, possessing a molecular weight of 412.48 g·mol⁻¹ and an empirical formula of C₂₅H₂₄N₄O₂. Solubility in dimethyl sulfoxide exceeds 20 mg·mL⁻¹, providing clear, pale yellow stock solutions; aqueous solubility is negligible (<0.1 mg·mL⁻¹ in phosphate-buffered saline at pH 7.4). Unlike the pan-kinase inhibitor staurosporine, GF 109203X exhibits pronounced selectivity for the classical (cPKC) isoforms PKCα, βI, βII, and γ, with published Ki values determined by ATP-competitive inhibition kinetics reaching 2.7 nM for PKCα and 4.5–18 nM for the β-subtypes when assayed in the presence of phosphatidylserine and diacylglycerol. This selectivity, combined with its inability to inhibit protein kinase A (PKA) or protein kinase G (PKG) at concentrations up to 10 µM, has established the compound as a reference tool for interrogating PKC-dependent signal transduction in mammalian cells, platelets, and neuronal preparations.
Lot-release testing adheres to a multi-parametric quality protocol. Identity is verified by high-resolution mass spectrometry (ESI + TOF) with an observed [M+H]⁺ ion at m/z 413.2, matching the theoretical monoisotopic mass within 3 ppm. Reverse-phase HPLC on a 4.6 mm × 150 mm C18 column (5 µm particle size) employing a water‑acetonitrile gradient containing 0.1 % trifluoroacetic acid and UV detection at 254 nm routinely returns a main peak area of ≥98.0 %. Residual solvent content is monitored by headspace GC‑MS per USP 〈467〉; typical dimethyl sulfoxide carry-over is held below 0.05 %. Water content, determined by Karl Fischer coulometric titration in accordance with USP 〈921〉, is controlled to ≤0.5 %. The table below summarizes the routine certificate-of-analysis parameters for a representative lot.
| Parameter | Specification | Typical Value | Method |
|---|---|---|---|
| Purity (HPLC) | ≥ 98.0 % area | 99.1 % | In-house RP‑HPLC, UV 254 nm |
| Identity (HRMS) | [M+H]⁺ deviation < 5 ppm | 1.8 ppm | ESI + TOF |
| Water content | ≤ 0.5 % | 0.21 % | Karl Fischer titration (USP 〈921〉) |
| Residual DMSO | ≤ 0.1 % | < 0.02 % | Headspace GC‑MS (USP 〈467〉) |
| Appearance | Off-white to pale yellow powder | Pale yellow powder | Visual inspection |
| Endotoxin | ≤ 0.1 EU·mg⁻¹ | < 0.05 EU·mg⁻¹ | Kinetic chromogenic LAL |
Lyophilized or crystallized bulk material stored at −20 °C under desiccation and protection from light is retested annually and remains within specification for at least 24 months. Stock solutions prepared in anhydrous DMSO and aliquoted under argon are stable for 6 months at −20 °C with less than 2 % degradation as judged by HPLC. Repeated freeze‑thaw cycles exceeding 5 cycles promote the formation of a minor oxidative degradation product; single‑use aliquots are therefore recommended.
Kinase selectivity profiling across a panel of 50 human kinases, performed with a radiometric filter‑binding assay (³³P‑ATP) at an ATP concentration of 10 µM, illustrates the narrow target spectrum that differentiates GF 109203X from other bisindolylmaleimide‑based inhibitors. For the classical PKC isoforms, the half‑maximal inhibitory concentrations ranged from 8.4 nM (PKCα) to 18 nM (PKCβI) and 16 nM (PKCβII), while PKCγ returned an IC₅₀ of 15 nM. Activity against the novel isoform PKCδ was notably weaker, with an IC₅₀ of 210 nM, and PKCε remained largely unaffected (IC₅₀ > 20 µM). PKA, PKG, calcium‑calmodulin‑dependent kinase II, and myosin light‑chain kinase all exhibited IC₅₀ values exceeding 10 µM, confirming a selectivity window greater than 1000‑fold over these off‑targets. This profile contrasts sharply with that of Ro 31‑8220 (bisindolylmaleimide IX), which, despite a comparable PKCα IC₅₀ of 10 nM, inhibits MAPKAP‑K1b with an IC₅₀ of 15 nM and furthermore attenuates p70 S6 kinase and MSK1 at sub‑micromolar concentrations. In direct comparison, GF 109203X shows no measurable activity on MAPKAP‑K1b up to 10 µM. Similarly, Gö 6983—another dimethylaminopropyl‑substituted maleimide—inhibits PKC with a potency of 7 nM but additionally reduces the activity of PKD/PKCμ and certain tyrosine kinases at concentrations below 100 nM; GF 109203X remains inert on PKD at 5 µM. The structural basis for these selectivity differences resides in the substitution pattern on the indole nitrogen: the dimethylaminopropyl chain is essential for high‑affinity binding to the ATP pocket of classical PKCs, yet the absence of additional modifications on the opposite indole ring (as seen in Gö 6983) limits off‑target polypharmacology. Thus, for experiments where exclusive interrogation of cPKC isoforms is required, GF 109203X remains the most discriminating tool among the commercially available bisindolylmaleimides.Application in intact cells demands careful attention to serum protein binding and plastic adsorption. In the presence of 10 % fetal bovine serum, the apparent IC₅₀ for PKCα‑mediated phosphorylation of MARCKS in Rat‑1 fibroblasts shifts from 0.4 µM to 1.2 µM; therefore, dose‑response experiments are typically performed at final concentrations of 1–5 µM with a 30‑min pre‑incubation before stimulation with phorbol ester. At 1 µM, GF 109203X suppressed PMA‑induced MARCKS phosphorylation by >90 % as quantified by phospho‑specific immunoblotting. Exceeding 5 µM for continuous exposure beyond 24 h is discouraged because of cytotoxicity manifested as caspase‑3 activation and mitochondrial membrane depolarization; this effect becomes pronounced above 8 µM in HEK293 and Jurkat lines. In vitro kinase reactions using recombinant cPKC isoforms are conducted at 10 nM inhibitor in the presence of 100 µM ATP, and the competitive mode with respect to ATP means that assays utilizing saturating ATP (> 1 mM) require a proportional upward adjustment of inhibitor concentration. A common pitfall is the use of polypropylene microcentrifuge tubes for serial dilutions; the lipophilic bisindolylmaleimide core exhibits significant adsorption to polypropylene, resulting in apparent potency losses of up to 40 %. Solutions should be prepared and stored in glass vials or low‑protein‑binding polyethylene containers. Water‑based working dilutions must be used within 2 h, as the compound slowly hydrolyses at pH > 7.5. Furthermore, unlike the PKC inhibitor chelerythrine, which competes with the regulatory phospholipid cofactor, GF 109203X competes directly with ATP; consequently, its inhibitory efficacy under high intracellular ATP conditions (∼5 mM) is diminished, a limitation that must be considered when interpreting negative results in metabolically active cells. For every cell‑based assay, parallel treatment with the catalytically inactive structural analog bisindolylmaleimide VIII at 5 µM serves as a critical negative control to confirm PKC‑dependent phenotypes.